News & Events

Noble LSP serves as Sole Co-Manager for Cynapsus Therapeutics (CYNA) $72,450,000 initial public offering (IPO)

June 2015

News

Noble LSP serves as Co-Manager for Heron Therapeutics (HRTX) $136,600,000 public offering

June 2015

News

Noble Life Science Partners and JSB Partners Forge Strategic Relationship

June 2015

News

Noble Life Science Partners, a division of Noble Financial Capital Markets (Noble) today announced that the company has formed a strategic partnership agreement with Boston-based JSB-Partners (JSB).

Finance Conference Spotlights Opportunities for Investors

News

For decades, the business of radio and television has been a reliable money-maker for investors large and small. However, the advent of the Web and mobile delivery platforms, plus the explosion in streaming media enterprises such as Netflix and Pandom, have made this once-simple investment opportunity complicated
and confusing for non-technical capitalists.

Galena Biopharma Announces Closing of Public Offering of Common Stock and Warrants

PORTLAND, Ore., March 18, 2015 (Globe Newswire)

News

Galena Biopharma, Inc. (GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care, today announced the closing of its previously announced underwritten public offering of 24,358,974 shares of common stock, and warrants to purchase an aggregate of 12,179,487 shares of common stock at an exercise price of $2.08 per share.

Noble Financial 11th Annual Conference Location Used as Backdrop for Launch of Its New Website

Boca Raton, March 25 2015

News

Noble Financial Capital Markets (Noble) today announced the launch of its new corporate website. The majority of photography and inspiration for the site comes from the location of the company's 11th Annual Equity / Investor Conference: Club Med, located in Sandpiper Bay, South Florida.

Galena Biopharma Announces Closing of Public Offering of Common Stock and Warrants

PORTLAND, Ore., March 18, 2015 (Globe Newswire)

News

Galena Biopharma, Inc. (GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care, today announced the closing of its previously announced underwritten public offering of 24,358,974 shares of common stock, and warrants to purchase an aggregate of 12,179,487 shares of common stock at an exercise price of $2.08 per share.

Noble LSP Co-Manager in Galena Biopharma, Inc. (GALE) $38,000,000 public offering

March 2015

News

Noble LSP Sole placement agent in Cynapsus Therapeutics, Inc. (CTH.TO & CYNAF) $16,750,000 private placement

March 2015

News

Overseas deals send Martha Stewart stock soaring

New York Post, March 17, 2015

News

For Martha Stewart, a very good thing appears about to happen — and her stock price is soaring to its highest price since mid-May 2010. It closed at $6.36 on Monday, up 14 percent on the day.

NAB Media Finance and Investor Conference

April 12-15, 2015, Wynn Hotel, Las Vegas #NABShow

Event

30 public companies in the media space. Panel discussions. Individual company meetings. 1-On-1 meetings. Breakfast, lunch and dinner meetings. Private exhibitor floor tours. Get into the business of the media business.

Noble LSP serves as Financial Advisor to Conkwest (Private) $50,000,000 strategic investment

January 2015

News

Western Digital's second-quarter results beat Street on strong enterprise growth

News

(Reuters) - Western Digital Corp, the world's No. 1 hard-disk drive maker, reported second-quarter results slightly ahead of Wall Street expectations on strong demand for its solid-state drives from enterprise customers.

Noble LSP serves as Co-Placement Agent for Palatin Technologies (PTN) $30,000,000 private placement

December 2014

News

Conkwest Announces $50m In Strategic Investments

San Diego, Dec. 24, 2014 /PRNewswire/

News

Conkwest, Inc., the Natural Killer Cell Company of the West, developing the proprietary Natural Killer (NK) cell-line platform, Neukoplast® (NK-92™) as an immuno-oncology therapeutic, announces that Dr. Patrick Soon-Shiong, NantWorks founder, physician scientist and biotechnology entrepreneur, has entered into a definitive agreement to purchase approximately $48 million of the Company's Class A Common Stock.

Noble LSP serves as Co-Manager for TherapeuticsMD (TXMD) $46,000,000 public offering

July 2014

News

Noble LSP serves as Co-Manager for LaJolla Pharmaceuticals (LJPC) $56,600,000 public offering

July 2014

News

Noble LSP serves as Co-Manager for Heron Therapeutics (HRTX) $60,000,000 public offering

June 2014

News

Noble LSP serves as Financial Advisor for OncoSec (ONCS) $16,000,000 registered direct offering

June 2014

News

Noble LSP serves as Co-Manager for BioCryst Pharmaceuticals (BCRX) $155,000,000 public offering

May 2014

News

1234